FDA Inspection 1125668 — Adam S. Giermasz, M.D., Ph.D.
The FDA completed an inspection of Adam S. Giermasz, M.D., Ph.D. on July 17, 2020 in Sacramento, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 17, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Sacramento, CA (United States)